MedPath

Awake Pronation for Covid-19 Treatment

Not Applicable
Conditions
Covid-19 Infection
Interventions
Procedure: Prone Position (PP)
Registration Number
NCT04667286
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

Observational studies have shown that prone position (PP) in spontaneously breathing patients, may improve oxygenation in individuals with Acute Respiratory Failure (ARF), due to Covid-19 infection.

None so far have evaluated the clinical efficacy of this approach on the patients' outcomes and in a randomised control fashion

Detailed Description

Observational studies have shown that prone position (PP) in spontaneously breathing patients, may improve oxygenation in individuals with Acute Respiratory Failure (ARF), due to Covid-19 infection.

These studies were mainly physiological and reported in a subset of patients a poor tolerance. Indeed most of the beneficial effects on gas exchage disappeared in around 40% of tyhe patients, once the patients regained the supine position.

None so far have evaluated the clinical efficacy of this approach on the patients' outcomes and in a randomised control fashion.

This holds particularly true in those patients affected by mild de-novo ARF (PaO2/FiO2 ratio within the range of 200-300), where any form of respiratory support like Continuous Positive Airways Pressure (CPAP), High Flow Nasal Cannula (HFNC) or Noninvasive ventilation (NIV), may be not yet indicated, especially if the patients are admitted to a regular ward as for the case of Covid-19 pandemics, due to the lack of "protected" beds.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • confirmed COVID-19 infection using PCR
  • Acute Respiratory Failure ( 200 <PaO2/FiO2 <300) and respiratory rate < 30 atti/min
  • O2 therapy initiated <72 hrs
  • informed consent
Exclusion Criteria
  • Glasgow Coma Scale (GCS) < 13
  • pH< 7,45, PaCO2 >45 mmHg
  • need for HFNC, CPAP, NIV or intubation
  • hemodynamic instability increase of 80-90 mmHg or reduction of 30-40 mmHg in systolic blood pressure
  • severe arrythmia of myocardial infarction
  • need for sedation
  • intolerance to PP
  • pregnancy
  • Body mass index (BMI) > 35 kg/m2.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oxygen and Prone Position (PP)Prone Position (PP)Oxygen via a Venturi mask in order to keep an oxygen saturation between 92 and 96% plus PP for a minimum of 10 hrs a day
OxygenProne Position (PP)Oxygen via a Venturi mask in order to keep an oxygen saturation between 92 and 96%
Primary Outcome Measures
NameTimeMethod
number of day free of ventilatory support1 month

number of days in which the patient will not need (according to standardized criterai) any for of these ventilatory support like NIV,CPAP, HFNC or intubation

Secondary Outcome Measures
NameTimeMethod
changes in respiratory pattern1 month

recording of tidal volume (when possible) and respiratory frequency

daily changes in the ratio SaO2/FiO21 month

Daily changes in oxygen saturation (SaO2) and Fraction of Inspired Oxygen (FiO2)

dyspnea1 month

using a dedicated scale (i.e. Borg numbered from 0 to 10)

comfort during PP1 month

using a dedicated visual analog scale (VAS with a lenght of 20 cm)

Trial Locations

Locations (3)

Sant'Orsola Malpighi

🇮🇹

Bologna, Italy

Bolzano Hospital

🇮🇹

Bolzano, Italy

University of Modena

🇮🇹

Modena, Italy

© Copyright 2025. All Rights Reserved by MedPath